. Author manuscript; available in PMC: 2019 Apr 1.

Published in final edited form as: Adm Policy Ment Health. 2018 Mar;45(2):276–285. doi: 10.1007/s10488-017-0822-1

Table 3.

Adjusted difference in differences estimates of PBHCI impacts on quality measures

	Wave 1					Wave 2
Quality of Care Measure	Estimate¹	Standard Error	95% Confidence Interval	Z-Score	P-value	Estimate¹	Standard Error	95% Confidence Interval	Z-Score	P-value
Outpatient Medical Visit	−0.075	0.052	(−0.18, 0.03)	−1.44	0.15	0.05	0.103	(−0.15, 0.25)	0.48	0.63
HbA1c monitoring for beneficiaries with diabetes	0.14	0.092	(−0.04, 0.32)	1.56	0.1179	−0.10	0.177	(−0.44, 0.25)	−0.55	0.5852
Glucose/HbA1c screening for beneficiaries on antipsychotic	0.22	0.054	(0.12, 0.33)	4.12	<.0001	−0.02	0.108	(−0.23, 0.20)	−0.15	0.8799
LDL/Cholesterol screening for beneficiaries on antipsychotic	0.21	0.045	(0.12, 0.30)	4.55	<.0001	0.07	0.089	(−0.11, 0.24)	0.75	0.4527

PBHCI=Primary Behavioral Health Care Integration; HbA1c=Hemoglobin A1c; LDL=Low-Density Lipoprotein.

Positive difference in differences estimates indicate gains over time in quality measure performance in PBHCI clinics relative to Control clinics.